Y-Mabs Therapeutics (YMAB.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug8

Y-Mabs Therapeutics released FY2025 Q2 earnings on August 8 Pre-Market EST, actual revenue USD 19.53 M (forecast USD 18.4 M), actual EPS USD -0.0714 (forecast USD -0.2625)

13:30

Y-Mabs Therapeutics released FY2025 Semi-Annual Earnings on August 8 Pre-Market EST, with actual revenue of USD 40.43 M and EPS of USD -0.1865

13:30

Jul15

Y-mAbs Therapeutics Holds Annual Shareholder Meeting

20:16

May29

Y-mAbs Therapeutics Inc. Makes Progress in Radiopharmaceutical Development

09:18

May27

Woven Health Presents Consensus Poster at Neuroblastoma Research Progress Conference

15:47

May26

Y-mAbs Displays Progress in GD2-SADA Cancer Treatment

14:02

Schedules & Filings

Schedules

Filings

Aug8

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 19.53 M, Net Income -3.239 M, EPS -0.0714

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 20.9 M, Net Income -5.196 M, EPS -0.1151

Mar4

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 26.5 M, Net Income -6.79 M, EPS -0.152

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More